MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEPAGE, G. A.
Right arrow Articles by JUNGA, I. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEPAGE, G. A.
Right arrow Articles by JUNGA, I. G.

Molecular Pharmacology, Vol 3, 37-43, Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics

The Utilization of agr-2'-Deoxythioguanosine by Murine Tumor Cells

G. A. LEPAGE 1 and I. G. JUNGA 1

1 Life Sciences Research, Stanford Research Institute, Menlo Park, California 94025

The agr- and beta-anomers of 2'-deoxythioguanosine were prepared with a radiocarbon label in the sugar moiety and a radiosulfur label in the base. In vivo experiments were conducted with Mecca Lymphosarcoma ascites cells in mice. Determination of the distribution of radioactivity in base and sugar of material incorporated into deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), relative to the distribution in the precursors, indicated that both anomers can be incorporated into the DNA without the separation of sugar and base. Degradation of DNA containing label from these nucleotide precursors, with deoxyribonuclease and phosphodiesterase, showed that the beta-anomer was almost all present in the nucleotide chain. The incorporation of agr-anomer into DNA gave a much higher proportion of terminal labeling, but also indicated that some agr-nucleoside had entered the nucleotide chain. The data also indicated that entry of agr-deoxynucleoside into the RNA can occur without exchange of the sugar.

Note:
ACKNOWLEDGMENT This work was supported by Contract PH 43-65-575 with the Cancer Chemotherapy National Service Center, National Cancer Institute, National Institutes of Health.

Submitted on July 18, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics